White Collar and Government Investigations, Securities & Financial Services Litigation partner Robert Heim was quoted in The New York Times article, “Ex-Fund Manager Settles Insider Trading Claims.” The article discusses the $600,000 settlement of federal insider trading charges between a former hedge fund manager, Stephen Goldfield and a pharmaceutical executive. The charges included making $13.98 million in illegal profits by trading in MedImmune securities before AstraZeneca agreed to acquire the company for more than $15 billion.

Robert states, “Mr. Goldfield is happy with the settlement and is looking forward to putting the matter behind him.”

To read the full article, click here.